Literature DB >> 22777116

Temperature and cell-type dependency of sulfide effects on mitochondrial respiration.

Michael Groeger1, Jose Matallo, Oscar McCook, Florian Wagner, Ulrich Wachter, Olga Bastian, Saskia Gierer, Vera Reich, Bettina Stahl, Markus Huber-Lang, Csaba Szabó, Michael Georgieff, Peter Radermacher, Enrico Calzia, Katja Wagner.   

Abstract

Previous studies suggest that sulfide-induced inhibition of cytochrome c oxidase (cCox) and, consequently, the metabolic and toxic effects of sulfide are less pronounced at low body temperature. Because the temperature-dependent effects of sulfide on the inflammatory response are still a matter of debate, we investigated the impact of varying temperature on the cCox excess capacity and the mitochondrial sulfide oxidation by the sulfide-ubiquinone oxidoreductase in macrophage-derived cell lines (AMJ2-C11 and RAW 264.7). Using an oxygraph chamber, the inhibition of mitochondrial respiration was measured by stepwise titrations with sulfide and the nonmetabolizable cCox inhibitor sodium azide at 25°C and 37°C. Using the latter of the two inhibitors, the excess capacity of the cCox was obtained. Furthermore, we quantified the capacity of these cells to withstand sulfide inhibition by measuring the amount required to inhibit respiration by 50% and 90% and the viability of the cells after 24-h exposure to 100 ppm of hydrogen sulfide. At low titration rates, the AMJ2-C11 cells, but not the RAW 264.7 cells, increased their capacity to withstand exogenously added sulfide. This effect was even greater at 25°C than at 37°C. Furthermore, only the AMJ2-C11 cells remained viable after sulfide exposure for 24 h. In contrast, only in the RAW 264.7 cells that an increase in cCox excess capacity was found at low temperatures. In macrophage-derived cell lines, both the excess capacity of cCox and the efficiency of sulfide elimination may increase at low temperatures. These properties may modify the effects of sulfide in immune cells and, potentially, the inflammatory response during sulfide exposure at different body temperatures.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22777116     DOI: 10.1097/SHK.0b013e3182651fe6

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  14 in total

Review 1.  Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects.

Authors:  Katalin Módis; Eelke M Bos; Enrico Calzia; Harry van Goor; Ciro Coletta; Andreas Papapetropoulos; Mark R Hellmich; Peter Radermacher; Frédéric Bouillaud; Csaba Szabo
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 2.  Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part I. Biochemical and physiological mechanisms.

Authors:  Csaba Szabo; Céline Ransy; Katalin Módis; Mireille Andriamihaja; Baptiste Murghes; Ciro Coletta; Gabor Olah; Kazunori Yanagi; Frédéric Bouillaud
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 3.  H2S during circulatory shock: some unresolved questions.

Authors:  Oscar McCook; Peter Radermacher; Chiara Volani; Pierre Asfar; Anita Ignatius; Julia Kemmler; Peter Möller; Csaba Szabó; Matthew Whiteman; Mark E Wood; Rui Wang; Michael Georgieff; Ulrich Wachter
Journal:  Nitric Oxide       Date:  2014-03-18       Impact factor: 4.427

4.  The Effects of Genetic 3-Mercaptopyruvate Sulfurtransferase Deficiency in Murine Traumatic-Hemorrhagic Shock.

Authors:  Michael Gröger; Martin Wepler; Ulrich Wachter; Tamara Merz; Oscar McCook; Sandra Kress; Britta Lukaschewski; Sebastian Hafner; Markus Huber-Lang; Enrico Calzia; Michael Georgieff; Noriyuki Nagahara; Csaba Szabó; Peter Radermacher; Clair Hartmann
Journal:  Shock       Date:  2019-04       Impact factor: 3.454

5.  S-Sulfhydration of ATP synthase by hydrogen sulfide stimulates mitochondrial bioenergetics.

Authors:  Katalin Módis; YoungJun Ju; Akbar Ahmad; Ashley A Untereiner; Zaid Altaany; Lingyun Wu; Csaba Szabo; Rui Wang
Journal:  Pharmacol Res       Date:  2016-08-20       Impact factor: 7.658

6.  Sulfide-inhibition of mitochondrial respiration at very low oxygen concentrations.

Authors:  J Matallo; J Vogt; O McCook; U Wachter; F Tillmans; M Groeger; C Szabo; M Georgieff; P Radermacher; E Calzia
Journal:  Nitric Oxide       Date:  2014-06-22       Impact factor: 4.427

Review 7.  Is pharmacological, H₂S-induced 'suspended animation' feasible in the ICU?

Authors:  Pierre Asfar; Enrico Calzia; Peter Radermacher
Journal:  Crit Care       Date:  2014-03-18       Impact factor: 9.097

8.  AP39, a Mitochondria-Targeted Hydrogen Sulfide Donor, Supports Cellular Bioenergetics and Protects against Alzheimer's Disease by Preserving Mitochondrial Function in APP/PS1 Mice and Neurons.

Authors:  Feng-Li Zhao; Fang Fang; Pei-feng Qiao; Ning Yan; Dan Gao; Yong Yan
Journal:  Oxid Med Cell Longev       Date:  2016-01-31       Impact factor: 6.543

9.  Compared effects of inhibition and exogenous administration of hydrogen sulphide in ischaemia-reperfusion injury.

Authors:  Khodor Issa; Antoine Kimmoun; Solène Collin; Frederique Ganster; Sophie Fremont-Orlowski; Pierre Asfar; Paul-Michel Mertes; Bruno Levy
Journal:  Crit Care       Date:  2013-07-10       Impact factor: 9.097

10.  Effects of glycemic control on glucose utilization and mitochondrial respiration during resuscitated murine septic shock.

Authors:  Josef A Vogt; Ulrich Wachter; Katja Wagner; Enrico Calzia; Michael Gröger; Sandra Weber; Bettina Stahl; Michael Georgieff; Pierre Asfar; Eric Fontaine; Peter Radermacher; Xavier M Leverve; Florian Wagner
Journal:  Intensive Care Med Exp       Date:  2014-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.